Add Yahoo as a preferred source to see more of our stories on Google. Martin Shkreli - Credit: Getty Images In the latest chapter in the legal battle over the Wu-Tang Clan’s Once Upon a Time in ...

Convicted hedge fund manager Martin Shkreli said two Wu-Tang Clan rappers are contractually committed to fund his defense—and any judgment against him—in a trade secrets case over the group’s one-of-a ...

NEW YORK CITY -- Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal ...

When he was CEO of Turing Pharmaceuticals, Martin Shkreli inflated the price of a drug used during treatment for cancer and AIDS by 5,000 percent over night. Amidst the controversy, he was arrested on ...

Companies founded by notorious "Pharma Bro" Martin Shkreli have agreed to pay up to $28 million to settle a class-action lawsuit related to claims they illegally thwarted competition to the ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million repayment order. This decision marks another setback for the former ...

In a Spaces interview on X, 'Pharma Bro' Martin Shkreli alleged that he created the DJT cryptocurrency with Barron Trump. Convicted Pharma Bro Martin Shkreli makes surprise appearance at SBF trial ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in ...

Former Turing Pharmaceutical CEO Martin Shkreli has started a bidding war on Twitter to win the chance to sock one to the industry’s notorious Pharma Boy, reports San Francisco Gate. Mr. Shkreli ...

Rapper Ghostface Killah of the Wu-Tang Clan attends a press conference to announce that the Wu-Tang Clan has signed with Warner Bros.Chelsea Lauren—WireImage/Getty Images The feud is on. Dennis Coles, ...

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. What Happened: On Saturday, in a post on X, ...